Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial

Medicine & Life Sciences

• Type 1 Diabetes Mellitus 64%
• Randomized Controlled Trials 48%
• Random Allocation 40%
• Control Groups 38%
• Insulin 35%
• Child 31%
• N-(4-((1-acetoamidoyl-4-piperidyl)oxy)phenyl)-N-((7-amidino-2-naphtyl)methyl)sulfamoyl acetic acid 26%
• Diabetic Ketoacidosis 26%
• National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) 16%
• Smartphone 12%
• Safety 12%
• Hypoglycemia 9%
• Intention 9%
• Hyperglycemia 9%
• Software 7%
• Pediatrics 6%
• Glucose 6%
• Therapeutics 5%
• Population 4%

Business & Economics

• Randomized Controlled Trial 100%
• Diabetes 89%
• Insulin 36%
• Randomization 23%
• Efficacy 13%
• Adverse Events 12%
• Therapy 11%
• Sensor 11%
• Telephone 9%
• Safety 8%
• Glucose 7%
• Kidney 6%
• Clinical Trials 5%
• Pediatrics 5%
• Registration 5%
• Smartphone 5%
• Funding 4%
• Screening 4%
• Prototype 4%
• Median 4%
• Multinationals 4%
• Inclusion 3%
• Software 3%
• United States of America 1%